Sign In
Buy XXII
22nd Century Group Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | -$0.240 |
| EPS actual | -$1.01 |
| EPS Surprise | -322.50% |
| Revenue estimate | 4.61M |
| Revenue actual | 4.105M |
| Revenue Surprise | -10.95% |
| Release date | Mar 26, 2026 |
| EPS estimate | -$0.420 |
| EPS actual | -$1.18 |
| EPS Surprise | -180.48% |
| Revenue estimate | 4.05M |
| Revenue actual | 3.537M |
| Revenue Surprise | -12.67% |
| Release date | Nov 04, 2025 |
| EPS estimate | -$251.85 |
| EPS actual | -$15.89 |
| EPS Surprise | 93.69% |
| Revenue estimate | 4.2M |
| Revenue actual | 4.011M |
| Revenue Surprise | -4.50% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.93 |
| EPS actual | -$1.97 |
| EPS Surprise | -111.81% |
| Revenue estimate | 5.44M |
| Revenue actual | 4.083M |
| Revenue Surprise | -24.94% |
Last 4 Quarters for 22nd Century Group
Below you can see how XXII performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $720.00 |
| EPS estimate | -$0.93 |
| EPS actual | -$1.97 |
| EPS surprise | -111.81% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $729.00 |
| Aug 11, 2025 | $690.00 |
| Aug 12, 2025 | $714.00 |
| Aug 13, 2025 | $801.00 |
| Aug 14, 2025 | $720.00 |
| Aug 15, 2025 | $702.00 |
| Aug 18, 2025 | $702.00 |
| Aug 19, 2025 | $672.00 |
| Aug 20, 2025 | $657.00 |
| 4 days before | -1.23% |
| 4 days after | -8.75% |
| On release day | -2.50% |
| Change in period | -9.88% |
| Release date | Nov 04, 2025 |
| Price on release | $387.00 |
| EPS estimate | -$251.85 |
| EPS actual | -$15.89 |
| EPS surprise | 93.69% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $483.00 |
| Oct 30, 2025 | $435.00 |
| Oct 31, 2025 | $453.00 |
| Nov 03, 2025 | $465.00 |
| Nov 04, 2025 | $387.00 |
| Nov 05, 2025 | $381.00 |
| Nov 06, 2025 | $372.00 |
| Nov 07, 2025 | $372.00 |
| Nov 10, 2025 | $387.00 |
| 4 days before | -19.88% |
| 4 days after | 0% |
| On release day | -1.55% |
| Change in period | -19.88% |
| Release date | Mar 26, 2026 |
| Price on release | $58.80 |
| EPS estimate | -$0.420 |
| EPS actual | -$1.18 |
| EPS surprise | -180.48% |
| Date | Price |
|---|---|
| Mar 20, 2026 | $71.40 |
| Mar 23, 2026 | $70.20 |
| Mar 24, 2026 | $68.60 |
| Mar 25, 2026 | $65.80 |
| Mar 26, 2026 | $58.80 |
| Mar 27, 2026 | $48.20 |
| Mar 30, 2026 | $47.20 |
| Mar 31, 2026 | $44.20 |
| Apr 01, 2026 | $44.20 |
| 4 days before | -17.65% |
| 4 days after | -24.83% |
| On release day | -18.03% |
| Change in period | -38.10% |
| Release date | May 07, 2026 |
| Price on release | $14.23 |
| EPS estimate | -$0.240 |
| EPS actual | -$1.01 |
| EPS surprise | -322.50% |
| Date | Price |
|---|---|
| May 01, 2026 | $27.40 |
| May 04, 2026 | $19.84 |
| May 05, 2026 | $16.80 |
| May 06, 2026 | $17.02 |
| May 07, 2026 | $14.23 |
| May 08, 2026 | $12.66 |
| May 11, 2026 | $11.89 |
| May 12, 2026 | $11.62 |
| May 13, 2026 | $13.91 |
| 4 days before | -48.05% |
| 4 days after | -2.29% |
| On release day | -11.09% |
| Change in period | -49.24% |
22nd Century Group Earnings Call Transcript Summary of Q1 2026
22nd Century Group is shifting fully to execution and commercial growth in 2026, focused on expanding distribution and consumer adoption of its FDA-authorized very low nicotine (VLN) cigarettes. Q1 2026 revenue was $4.1 million (up 16% sequentially from Q4 2025) with a gross loss of $0.6 million and an operating loss of $3.0 million; adjusted EBITDA was negative $2.6 million. The company secured initial distribution of Pinnacle VLN with two of the top U.S. tobacco purveyors and plans additional rollouts (New York, New Jersey, Southern California, Southeast) to reach approximately 5,000 retail outlets by year-end 2026. Management is prioritizing targeted consumer marketing, merchandising, and hiring a VP of Marketing to drive awareness and adoption, while exiting low/no-margin contracts and improving product mix to lift gross margins. Cash and cash equivalents were $9.5 million at quarter end; capital allocation will focus on distribution growth, VLN commercial support, marketing, and reduced-nicotine R&D. Management expects non-linear near-term profitability but anticipates stronger commercial momentum in the back half of 2026 as distribution and marketing investments scale.
